MAD1L1 and TPM3

  • Number of citations of the paper that reports this interaction (PMID 25416956)
  • 0
  • Data Source:
  • BioGRID (two hybrid)

MAD1L1

TPM3

Gene Name MAD1 mitotic arrest deficient-like 1 (yeast) tropomyosin 3
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 38 interactors: ALOX5 AMOTL2 BAG5 CCDC94 CCHCR1 COIL CWF19L2 FAM131C HAUS1 HDAC1 HDAC2 LGALSL MAD2L1 MAX MFAP1 MLX NDC80 NEBL NEK2 NINL NONO PSMA1 RNF8 SIN3A SIN3B SPATA2 TEX11 TPM1 TPM3 TPR TRIM29 TSC22D3 TSHZ3 TUBGCP4 UBC UBTF USP15 ZSCAN32 41 interactors: ACTA1 ACTB BLOC1S6 C1orf216 CCDC102B CCDC114 CCDC146 CCHCR1 CNN1 FAM9C FBXO5 HDDC3 HSF2 IFIT3 IKBIP KCNE1 KIFC3 KXD1 LCA5L LURAP1 MAD1L1 MAGEA11 NEK2 OIP5 PBX3 S100A2 S100A4 SMAD3 SUMO4 SYCE1 TFPT THAP1 TLK1 TMOD1 TMOD2 TNNT1 TRAP1 TRIM27 TRIP6 VPS52 WASH3P
Entrez ID 8379 7170
HPRD ID 04065 01840
Ensembl ID ENSG00000002822 ENSG00000143549
Uniprot IDs B3KR41 Q9Y6D9 B4DQ80 P06753 Q5VU58 Q5VU63 Q8TCG3
PDB IDs 1GO4 4DZO
Enriched GO Terms of Interacting Partners?
Tagcloud ?
adverse  altered  aneuploidy  arrest  biomarker  carcinogenesis  characteristic  checkpoint  checkpoints  chromosomal  clinicopathological  contraindication  correlation  defects  instability  mammary  microarray  mitotic  nuclei  ones  os  pacilitaxel  predict  shorter  subtypes  taxol  undergone  whose  worse 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  ntrk1  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  transforming  trk  trka  trkb  trkc 
Tagcloud (Difference) ?
adverse  altered  aneuploidy  arrest  biomarker  carcinogenesis  characteristic  checkpoint  checkpoints  chromosomal  clinicopathological  contraindication  correlation  defects  instability  mammary  microarray  mitotic  nuclei  ones  os  pacilitaxel  predict  shorter  subtypes  taxol  undergone  whose  worse 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  ntrk1  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  transforming  trk  trka  trkb  trkc 
Tagcloud (Intersection) ?